Skip to content
zameds

Venlafaxine (Venlor, Venlor Xr, Venlafaxine Cipla, Venlafaxine Be-tabs Mr)

Venlafaxine

Cipla Medpro (Pty) Ltd

S5

Registration

Applicant
Cipla Medpro (Pty) Ltd
Registrations
17
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Venlor 37,5

EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 37,5 mg

37,537053337/1.2/0533RegisteredS5None
Venlor xr 225 MG tablet

EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 225,0 mg

225 mgTablet56003556/1.2/0035RegistreredS5None
Venlor xr 300 MG tablet

EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 300,0 mg

300 mgTablet56003656/1.2/0036RegistreredS5None
Venlor xr 37,5 MG tablet

EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 37,5 mg

37,5 mgTablet56003756/1.2/0037RegisteredS5None
Venlor xr 75 MG tablet

EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 75,0 mg

75 mgTablet56003856/1.2/0038RegisteredS5None
Venlor xr 150 MG tablet

EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 150,0 mg

150 mgTablet56003956/1.2/0039RegisteredS5None
Venlor xr 225

EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO: VENLAFAXINE 225,0 mg

225Extended-release capsules59021259/1.2/0212Approved 7 November 2024RegisteredS5PIPIL
Venlafaxine 225 cipla

EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO: VENLAFAXINE 225,0 mg

225590213.21259/1.2/0213.212RegisteredS5None
Venlafaxine 37,5 cipla

EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 37,5 mg

37,559038459/1.2/0384RegisteredS5None
Venlafaxine 75 cipla

EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO: VENLAFAXINE 75,0 mg

7559038559/1.2/0385RegisteredS5None
Venlafaxine 150 cipla

EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO: VENLAFAXINE 150,0 mg

15059038659/1.2/0386RegisteredS5None
Venlafaxine be-tabs mr 37,5

EACH CAPSULE CONTAINS VENLAFAXINE 37,5 mg

37,5A400029A40/1.2/0029CancelledS5None
Venlafaxine be-tabs mr 75

EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg

75A400030A40/1.2/0030CancelledS5None
Venlafaxine be-tabs mr 150

EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg

150A400031A40/1.2/0031CancelledS5None
Venlor xr 37,5

EACH CAPSULE CONTAINS VENLAFAXINE 37,5 mg

37,5Extended-release capsules.A400032A40/1.2/0032Approved 7 November 2024RegisteredS5PIPIL
Venlor xr 75

EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg

75Extended-release capsulesA400033A40/1.2/0033Approved 7 November 2024RegisteredS5PIPIL
Venlor xr 150

EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg

150Extended-release capsulesA400034A40/1.2/0034Approved 7 November 2024RegisteredS5PIPIL

Regulatory status

Where S5 sits on the scale

Prescription-only, with tighter controls on repeats.

Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.

Consolidated Schedules listings for Venlafaxine hydrochloride equivalent to venlafaxine

  • S5: Venlafaxine

    Consolidated Schedules 06 July 2026, line 9761

Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C17H27NO2277.40 g/mol

1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol

Drag to rotate. Structure from PubChem CID 5656.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S5) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles